Transparency Market Research in its new report titled, “Stem Cell Manufacturing Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the Stem Cell Manufacturing Market.
The global stem cell manufacturing market is mainly segmented on the basis of product, application, end user, and region. Under product type, stem cell lines, instruments, culture media, and consumables, are the primary segments present in this market. These are further divided into several sub-segments, which are explained in detail in the report. On the basis of application, research applications, clinical applications, and cell and tissue banking applications are prime segments existing in the global stem cell manufacturing market. Lastly, under end-users, this market is mainly segregated into several categories, viz. hospitals and surgical centers, pharmaceutical and biotech companies, cell banks and tissue banks, academic institutes, research laboratories, and CROs.
A rising awareness among the masses about the potential of stem cell products in medical applications is primarily causing the global stem cell manufacturing market to pick up rampant pace. Simultaneously, extensive advancements are occurring in the field of stem cell research and revolutionary techniques are being discovered almost every year. This has attracted a substantial number of people to work in this sector, consequently pushing the stem cell manufacturing market to gain boundless growth.
From a regional perspective, this market is segmented into North America, Asia Pacific, the Middle East and Africa, Europe, and Latin America. Of these, North America grabs the lion’s share in terms of revenue gained thanks to the presence of a strong healthcare infrastructure and rapidly increasing cases of ailments among the masses wherein stem cell manufacturing is highly needed.
A favorable reimbursement scenario showcased by governmental bodies for medical procedures has also made the market grow extensively in this region. Apart from North America, the next few years are expected to depict Europe as a thriving region in the global stem cell manufacturing market owing to rising geriatric population and high demand for relevant treatment processes.
Anterogen, Merck Group, Pharmicell, Becton, Bio-Rad Laboratories, Inc., Takara Bio Group, STEMCELL Technologies, Thermo Fisher Scientific, Osiris Therapeutics, Dickinson and Company, HolostemTerapieAvanzate, Cellular Dynamics International, MEDIPOST, MiltenyiBiotecGmBH, Lonza Group, and Pluristem Therapeutics, are some of the other major players operating in the stem cell manufacturing market.
Request a free brochure report here – http://bit.ly/2NUVMZ3
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
